NAD Deems Wellnx “Jean Size” Claim A Poor Fit
This article was originally published in The Tan Sheet
Executive Summary
The National Advertising Division says claims for Wellnx Life Sciences’ NV Hollywood weight loss supplement did not align with results of the firm’s studies, and the firm’s “Drop 1 jean size in 2 weeks” does not reflect a standardized measure of sizes.
You may also be interested in...
Slimquick Extreme Fails To Support “Clinically Proven” Claims – NAD
Clinical studies for Wellnx Life Sciences' weight-loss supplement Slimquick Extreme fail to meet standards necessary to support "clinically proven, strong, specific and quantified claims," the National Advertising Division says
IPO Update: Patheon Public Once Again, Audentes To Move Into The Clinic
Two companies in the biopharma space began trading publicly this week, one to pay off debt, the other to fund an early-stage pipeline.
Zafgen Drops Beloranib, But Its New Focus Raises Doubts
The biotech is shifting gears after clinical hold on its lead drug was unlikely to be lifted, but the early-stage candidate that it's placing its hopes on is raising red flags for analysts and investors.